IGHE and Alzheimer disease: These results suggest that CDE improves the treatment of disease through improving AD-related symptoms and gene regulation through the down-regulation of IgE and mite-specific IgE, as well as the increased dermal/epidermal thickness caused by AD and the down-regulation of pro-inflammatory cytokines.